Beckman Coulter Announces Investor Communication Events: Senior Management to Discuss Proposed Biosite Acquisition
March 25 2007 - 5:52PM
PR Newswire (US)
FULLERTON, Calif., March 25 /PRNewswire-FirstCall/ -- Beckman
Coulter, Inc. (NYSE:BEC) announced today it will host a series of
Communication Events for investors and analysts to review the
company's proposed acquisition of Biosite, Inc. (NASDAQ:BSTE),
announced earlier today. These events include: (Logo:
http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) Investor
Webcast Beckman Coulter will host a webcast on Monday, March 26,
2007, at 8:30 am ET to discuss the transaction. The audio portion
of the event may be accessed by dialing (877) 516-3365 or (706)
679-3246 and asking for the Beckman Coulter conference call or
reservation #3687656. To participate via the website and obtain
access to the presentation materials, please go to Beckman
Coulter's website at http://www.beckmancoulter.com/ and select "go
to IR" under Investor Relations and find the call listed under
"What's Ahead". The webcast will be archived for future on-demand
replay. Group Meetings A series of five small group meetings for
institutional investors will be hosted by Scott Garrett, President
and Chief Executive Officer of Beckman Coulter. Other attendees
will include Charlie Slacik, Beckman Coulter's Chief Financial
Officer, Ken Buechler, President and Chief Scientific Officer of
Biosite, and Chris Hibberd Biosite's Senior Vice President,
Corporate Development. Members of the investment community who wish
to attend one of the following events should RSVP directly to
Investor Relations at (714) 773-7620 or to obtain meeting details.
Tuesday, March 27 - New York: Group Breakfast and Group Lunch
Wednesday, March 28 - Boston: Group Lunch Thursday, March 29 -
Chicago: Group Breakfast Thursday, March 29 - Minneapolis: Group
Dinner About Beckman Coulter Beckman Coulter, Inc., based in
Fullerton, California, develops, manufactures and markets products
that simplify automate, and innovate complex biomedical tests. More
than 200,000 Beckman Coulter systems operate in laboratories around
the world supplying critical information for improving patient
health and reducing the cost of care. Recurring revenues consisting
of supplies, test kits, service and operating-type lease payments
represent more than 75 percent of the company's 2006 annual sales
of $2.5 billion. For more information, visit
http://www.beckmancoulter.com/. Contact: Robert Raynor Director,
Investor Relations (714) 773-7620
http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGODATASOURCE:
Beckman Coulter, Inc. CONTACT: Robert Raynor, Director, Investor
Relations, +1-714-773-7620 Web site: http://www.beckmancoulter.com/
Copyright
Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Biosite (MM) (NASDAQ): 0 recent articles
More Biosite (MM) News Articles